Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Amgen, UCB's postmenopausal osteoporosis drug Evenity

firstwordpharmaApril 10, 2019

Tag: FDA , Amgen , postmenopausal osteoporosis

PharmaSources Customer Service